Bristol-Myers Immunotherapy Drug Impresses With Phase 2 Lung Cancer Data
October 30, 2014 at 21:22 PM EDT
Bristol-Myers posts outstanding results In lung cancer data using immunotherapy drug
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.